• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对癌症治疗的 DNA 修复途径:有何新进展?

Targeting DNA repair pathways for cancer treatment: what's new?

机构信息

Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

Future Oncol. 2014 May;10(7):1215-37. doi: 10.2217/fon.14.60.

DOI:10.2217/fon.14.60
PMID:24947262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4125008/
Abstract

Disruptions in DNA repair pathways predispose cells to accumulating DNA damage. A growing body of evidence indicates that tumors accumulate progressively more mutations in DNA repair proteins as cancers progress. DNA repair mechanisms greatly affect the response to cytotoxic treatments, so understanding those mechanisms and finding ways to turn dysregulated repair processes against themselves to induce tumor death is the goal of all DNA repair inhibition efforts. Inhibition may be direct or indirect. This burgeoning field of research is replete with promise and challenge, as more intricacies of each repair pathway are discovered. In an era of increasing concern about healthcare costs, use of DNA repair inhibitors can prove to be highly effective stewardship of R&D resources and patient expenses.

摘要

DNA 修复途径的中断使细胞容易积累 DNA 损伤。越来越多的证据表明,随着癌症的进展,肿瘤在 DNA 修复蛋白中积累的突变逐渐增多。DNA 修复机制极大地影响了对细胞毒性治疗的反应,因此了解这些机制并找到方法使失调的修复过程对自身产生作用,以诱导肿瘤死亡,是所有 DNA 修复抑制努力的目标。抑制可以是直接的,也可以是间接的。随着对每条修复途径的更多复杂性的发现,这个迅速发展的研究领域充满了希望和挑战。在人们越来越关注医疗保健成本的时代,使用 DNA 修复抑制剂可以被证明是对研发资源和患者费用的高度有效的管理。

相似文献

1
Targeting DNA repair pathways for cancer treatment: what's new?针对癌症治疗的 DNA 修复途径:有何新进展?
Future Oncol. 2014 May;10(7):1215-37. doi: 10.2217/fon.14.60.
2
Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach.在癌症治疗中抑制 DNA 修复:迈向多靶点方法。
Int J Mol Sci. 2020 Sep 12;21(18):6684. doi: 10.3390/ijms21186684.
3
DNA repair inhibitors in cancer treatment.癌症治疗中的DNA修复抑制剂
Clin Transl Oncol. 2006 Sep;8(9):642-6. doi: 10.1007/s12094-006-0034-8.
4
Biomarkers to assess the targeting of DNA repair pathways to augment tumor response to therapy.评估 DNA 修复途径靶向治疗以增强肿瘤对治疗反应的生物标志物。
Curr Mol Med. 2012 Jul 1;12(6):788-803. doi: 10.2174/156652412800792615.
5
DNA repair as treatment target.DNA修复作为治疗靶点。
Eur J Cancer. 2011 Sep;47 Suppl 3:S333-5. doi: 10.1016/S0959-8049(11)70192-7.
6
Molecular pathways: exploiting tumor-specific molecular defects in DNA repair pathways for precision cancer therapy.分子途径:利用肿瘤特异性 DNA 修复途径中的分子缺陷进行精准癌症治疗。
Clin Cancer Res. 2014 Dec 1;20(23):5882-7. doi: 10.1158/1078-0432.CCR-14-1165.
7
BRCA-FA pathway as a target for anti-tumor drugs.BRCA-FA通路作为抗肿瘤药物的靶点。
Anticancer Agents Med Chem. 2008 May;8(4):426-30. doi: 10.2174/187152008784220285.
8
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches.癌症相关的 DNA 修复途径缺陷作为个性化治疗方法的靶点。
Trends Genet. 2014 Aug;30(8):326-39. doi: 10.1016/j.tig.2014.06.003. Epub 2014 Jul 10.
9
Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment.通过丝氨酸/苏氨酸激酶抑制剂破坏 DNA 损伤反应,以改善癌症治疗。
Curr Med Chem. 2019;26(8):1425-1445. doi: 10.2174/0929867325666180117102233.
10
Targeting synthetic lethality in DNA damage repair pathways as an anti-cancer strategy.靶向 DNA 损伤修复途径中的合成致死作为一种抗癌策略。
Curr Drug Targets. 2010 Oct;11(10):1336-40. doi: 10.2174/1389450111007011336.

引用本文的文献

1
Parthanatos and apoptosis: unraveling their roles in cancer cell death and therapy resistance.PARP-1依赖性细胞坏死与细胞凋亡:揭示它们在癌细胞死亡和治疗抗性中的作用
EXCLI J. 2025 Mar 4;24:351-380. doi: 10.17179/excli2025-8251. eCollection 2025.
2
Inhibition of the metalloprotease ADAM19 as a novel senomorphic strategy to ameliorate gut permeability and senescence markers by modulating senescence-associated secretory phenotype (SASP).抑制金属蛋白酶ADAM19作为一种新型的衰老形态调节策略,通过调节衰老相关分泌表型(SASP)来改善肠道通透性和衰老标志物。
Aging (Albany NY). 2025 Mar 20;17(3):757-777. doi: 10.18632/aging.206224.
3

本文引用的文献

1
Chemotherapy-induced peripheral neurotoxicity: a critical analysis.化疗诱导的周围神经毒性:批判性分析。
CA Cancer J Clin. 2013 Nov-Dec;63(6):419-37. doi: 10.3322/caac.21204.
2
Beyond DNA Repair: Additional Functions of PARP-1 in Cancer.超越DNA修复:PARP-1在癌症中的其他功能
Front Oncol. 2013 Nov 27;3:290. doi: 10.3389/fonc.2013.00290.
3
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.化疗诱导感觉性周围神经毒性的医生评估和患者报告结局测量:同一枚硬币的两面。
Advancing cancer therapy: new frontiers in targeting DNA damage response.
推进癌症治疗:靶向DNA损伤反应的新前沿
Front Pharmacol. 2024 Sep 20;15:1474337. doi: 10.3389/fphar.2024.1474337. eCollection 2024.
4
Novel DNA Repair Inhibitors Targeting XPG to Enhance Cisplatin Therapy in Non-Small Cell Lung Cancer: Insights from In Silico and Cell-Based Studies.靶向XPG增强非小细胞肺癌顺铂治疗的新型DNA修复抑制剂:来自计算机模拟和细胞实验研究的见解
Cancers (Basel). 2024 Sep 16;16(18):3174. doi: 10.3390/cancers16183174.
5
Role of APE1 in hepatocellular carcinoma and its prospects as a target in clinical settings (Review).APEX1在肝细胞癌中的作用及其作为临床治疗靶点的前景(综述)
Mol Clin Oncol. 2024 Sep 6;21(5):82. doi: 10.3892/mco.2024.2780. eCollection 2024 Nov.
6
Genetic and Epigenetic Biomarkers Associated with Early Relapse in Pediatric Acute Lymphoblastic Leukemia: A Focused Bioinformatics Study on DNA-Repair Genes.与儿童急性淋巴细胞白血病早期复发相关的遗传和表观遗传生物标志物:关于DNA修复基因的聚焦生物信息学研究
Biomedicines. 2024 Aug 5;12(8):1766. doi: 10.3390/biomedicines12081766.
7
Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas.DNA 修复基因 RNase H2 的缺失鉴定出独特的 DDR 缺陷型平滑肌肉瘤亚群。
Mol Cancer Ther. 2024 Jul 2;23(7):1057-1065. doi: 10.1158/1535-7163.MCT-23-0761.
8
Live-cell imaging of human apurinic/apyrimidinic endonuclease 1 in the nucleus and nucleolus using a chaperone@DNA probe.利用伴侣蛋白@DNA 探针在细胞核和核仁中对人嘌呤/嘧啶内切核酸酶 1 进行活细胞成像。
Nucleic Acids Res. 2024 May 8;52(8):e41. doi: 10.1093/nar/gkae202.
9
Excavatolide C/cisplatin combination induces antiproliferation and drives apoptosis and DNA damage in bladder cancer cells.挖掘菌素 C/顺铂联合作用诱导膀胱癌细胞增殖抑制、凋亡和 DNA 损伤。
Arch Toxicol. 2024 May;98(5):1543-1560. doi: 10.1007/s00204-024-03699-1. Epub 2024 Feb 29.
10
New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.新型 Ref-1/APE1 靶向抑制剂在多种癌症类型的临床应用中显示出更高的效力。
Pharmacol Res. 2024 Mar;201:107092. doi: 10.1016/j.phrs.2024.107092. Epub 2024 Feb 2.
Ann Oncol. 2014 Jan;25(1):257-64. doi: 10.1093/annonc/mdt409. Epub 2013 Nov 19.
4
Breaking the invulnerability of cancer stem cells: two-step strategy to kill the stem-like cell subpopulation of multiple myeloma.打破癌症干细胞的无敌状态:两步策略杀死多发性骨髓瘤的干细胞样细胞亚群。
Mol Cancer Ther. 2014 Jan;13(1):144-53. doi: 10.1158/1535-7163.MCT-13-0240. Epub 2013 Oct 30.
5
O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas.O6-甲基鸟嘌呤 DNA 甲基转移酶作为替莫唑胺耐药脑胶质瘤治疗的有前途的靶点。
Cell Death Dis. 2013 Oct 24;4(10):e876. doi: 10.1038/cddis.2013.388.
6
The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy.黄酮类化合物芦丁和槲皮素的抗氧化作用抑制奥沙利铂诱导的慢性痛性周围神经病。
Mol Pain. 2013 Oct 23;9:53. doi: 10.1186/1744-8069-9-53.
7
Discovery of a potent inhibitor of replication protein a protein-protein interactions using a fragment-linking approach.利用片段连接方法发现一种有效的复制蛋白 A 蛋白-蛋白相互作用抑制剂。
J Med Chem. 2013 Nov 27;56(22):9242-50. doi: 10.1021/jm401333u. Epub 2013 Nov 11.
8
CHEK again: revisiting the development of CHK1 inhibitors for cancer therapy.CHEK 再次成为焦点:重新审视 CHK1 抑制剂在癌症治疗中的发展。
Pharmacol Ther. 2014 Apr;142(1):1-10. doi: 10.1016/j.pharmthera.2013.10.005. Epub 2013 Oct 15.
9
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy.加味八珍颗粒防治奥沙利铂神经毒性的临床研究(GONE):一项预防奥沙利铂神经毒性的 2 期、多中心、随机、双盲、安慰剂对照临床试验。
Cancer Chemother Pharmacol. 2013 Dec;72(6):1283-90. doi: 10.1007/s00280-013-2306-7.
10
Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children.比较两种儿童化疗引起的周围神经病测量方法。
Support Care Cancer. 2014 Feb;22(2):359-66. doi: 10.1007/s00520-013-1981-6. Epub 2013 Sep 27.